|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Prepaid income tax | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| NON-CURRENT ASSETS: | ||||||||||||||||||||
| Investment | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Long-term prepaid expenses and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY/(DEFICIT) | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Debt, current portion | ||||||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| NON-CURRENT LIABILITIES: | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Debt, non-current portion | ||||||||||||||||||||
| Operating lease liabilities - non-current | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY/(DEFICIT): | ||||||||||||||||||||
| Ordinary shares, £0.008 par value; 135,722,306 and 96,085,785 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Ordinary shares | ||||||||||||||||||||
| DEFERRED SHARES | ||||||||||||||||||||
| Total ordinary shares, £0.008 par value; 135,722,306 and 96,085,785 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Shares, issued (in shares) | ||||||||||||||||||||
| Ordinary shares | ||||||||||||||||||||
| DEFERRED SHARES | ||||||||||||||||||||
| Total shares, issued (in shares) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders' equity/(deficit) | ||||||||||||||||||||
| Total liabilities and shareholders' equity/(deficit) | ||||||||||||||||||||
| Common stock, par value (in GBP per share) | ||||||||||||||||||||
| Ordinary shares | ||||||||||||||||||||
| DEFERRED SHARES | ||||||||||||||||||||
| Total common stock, par value (in GBP per share) | ||||||||||||||||||||
| Fair value of underlying ordinary shares (in dollars per share) | ||||||||||||||||||||
| Ordinary shares | ||||||||||||||||||||
| DEFERRED SHARES | ||||||||||||||||||||
| Total fair value of underlying ordinary shares (in dollars per share) | ||||||||||||||||||||
Loading...
